TIDMAMP

RNS Number : 5404L

Amphion Innovations PLC

20 April 2018

Amphion Innovations plc

("Amphion" or "the Company")

Directorate Change

London and New York, 20 April 2018 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, announces that Miroslaw Izienicki and Richard Mansell-Jones have resigned as Non-executive Director and Chairman respectively and will leave the Board with immediate effect.

The Company has begun the process of seeking suitable candidates to fill these positions and will update shareholders accordingly.

Richard C.E. Morgan, Chief Executive Officer of Amphion said: "I would like to thank Miroslaw and Richard for their service to Amphion over the years. We wish them both well for the future.

"Our team at Amphion remains confident in the futures of Motif Bio and Polarean Imaging, both now publically listed companies, as well as the future potential of FireStar Software. We believe that as our companies' progress, Amphion's shareholders will benefit in turn and we look forward to building on that base with new investment opportunities in the life-sciences sector."

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

For further information please contact:

 
 Amphion Innovations                                      Tel: +1 (212) 210 6224 
 Charlie Morgan 
 
 Panmure Gordon Limited (Nominated Adviser                        Tel: +44 (0)20 
  and Corporate Broker)                                                7886 2500 
 Freddy Crossley / Ryan McCarthy / Emma 
  Earl (Corporate Finance) 
 Charlie Leigh-Pemberton (Corporate 
  Broking) 
 
 Northland Capital Partners Limited (Joint                   Tel: +44 (0)20 3861 
  Corporate Broker)                                                         6625 
 David Hignell (Corporate Finance) 
 John Howes (Corporate Broking) 
 
 Walbrook PR                                         Tel: +44 (0)20 7933 8780 or 
 Anna Dunphy / Paul McManus                               amphion@walbrookpr.com

About Amphion Innovations plc - www.amphionplc.com

Amphion Innovations is a developer of medical, life science and technology businesses. We use our extensive experience in company building to invest and build shareholder value in high growth companies in the US and UK. Amphion has significant shareholding in a small number of Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies.

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOAFMGMDMLGGRZZ

(END) Dow Jones Newswires

April 20, 2018 02:00 ET (06:00 GMT)

Amphion Innovations (LSE:AMP)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Amphion Innovations Charts.
Amphion Innovations (LSE:AMP)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Amphion Innovations Charts.